Corporate Profit Margins Hit 19.4%, Highest Since the 1940s, While GDP Grows Just 1.5%

American corporations just posted the fattest profit margins on record, and the economy underneath them barely budged.

The Bureau of Economic Analysis released data on August 26 showing corporate profits from current production jumped $400.9 billion in the second quarter of 2026. That is more than five times the $74.4 billion gain posted in the first quarter, according to Crypto Briefing's reporting on the BEA release.

After-tax profits as a share of gross value added hit 19.4%, up from 18.2% in Q1. That is the highest level since the BEA data series began in the 1940s. Total corporate profits, adjusted for inventory valuation and capital consumption, reached $4,827 billion on a seasonally adjusted annual rate basis, up roughly 9% from $4,426 billion in Q1.

Meanwhile, real GDP grew at just a 1.5% annualized rate in the second estimate. When corporate profits jump nearly 10% in a single quarter while the overall economy grows 1.5%, the math says companies are raising prices and cutting costs faster than the economy is actually expanding. Newsbytes App put it plainly: businesses managed to pass rising costs onto customers while people kept spending, even with higher prices and slow wage growth.

Richard Moody, chief economist at Regions Financial, framed the profit surge as good news for investment. "Profit growth is freeing up cash that is helping support business capital spending, with cap-ex growth extending beyond AI related investment," Moody said. Nonresidential fixed investment did expand at an 8.5% annualized pace in the quarter, backing up his point.

Wall Street's own numbers echo the government data. S&P 500 companies posted blended earnings growth of roughly 50% year-over-year this earnings season, with net profit margins hitting multi-year highs across the index.

Retailers Tell a Split Story

Not every company is riding the same wave. The Epoch Times reported that Target and Ross Stores saw rising customer traffic during the second-quarter earnings season, while TJX's Marmaxx division posted weaker-than-expected purchases and Walmart's strong headline numbers still missed Wall Street's targets.

Target's sales climbed, margins improved, and the company raised its full-year outlook, sending shares up 7% for the week, according to the Epoch Times. CEO Michael Fiddelke told analysts on August 19 the company is executing on merchandising, in-store experience, technology, and workforce investment simultaneously. But John Zolidis, president of Quo Vadis Capital, cautioned that much of Target's strength came from easy comparisons to a weak year-ago quarter and shoppers spending unusually generous tax refunds, not necessarily a durable turnaround.

Ross Stores had a cleaner win. Total sales jumped 13% year-over-year in the second quarter, comparable-store sales surged 10%, and the company raised guidance, sending shares up nearly 4.4% on August 21. CEO Jim Conroy credited more foot traffic and deeper engagement from returning customers.

The takeaway across retail is that Americans are still spending, just more selectively, chasing deals at off-price chains and value retailers rather than spreading it evenly.

The UnitedHealth Question

A separate study adds a pointed wrinkle to the profit-margin story, though it deserves scrutiny on its funding. Breitbart reported on findings from economist Nam D. Pham, commissioned by the Insurance Watchdog Coalition, a group that describes its mission as holding insurance conglomerates accountable. The study argues UnitedHealth Group's reported 7.6% average net margin from 2020 to 2025 understates its real profitability because the company counts pass-through medical claims payments as revenue.

Strip out those pass-through costs, Pham found, and UnitedHealth's operating margin averaged 33.0% of gross profit over that period, roughly four times the company's reported net margin. Pham compared that figure to top biopharmaceutical manufacturers, which he said posted similar margins around 33% of gross profits while reinvesting nearly 35% of gross profits into research and development. UnitedHealth, by Pham's accounting, devoted more than 62% of gross profit to selling, general, and administrative expenses and nothing to R&D.

That is a serious allegation about how one of the country's largest insurers presents its finances, but it comes from a study commissioned by an advocacy group built specifically to target the insurance industry, and UnitedHealth's response to Pham's methodology was not included in available reporting. Insurers have long argued that treating claims payments as revenue reflects how premium dollars actually flow through the business, similar to how a bank's total deposits aren't counted as bank revenue but the transaction itself still moves through its books. Whether Pham's brokerage-fee analogy is the more accurate framework, or whether standard insurance accounting already reflects the business correctly, is a methodological dispute the study alone doesn't settle.

What is not in dispute is the broader trend: corporate America, across sectors, is extracting more profit per dollar of economic activity than at any point in more than 80 years of BEA record-keeping. The open question is how long that holds if GDP growth stays stuck near 1.5% and consumers keep tightening their spending to deals-focused retailers rather than broad-based buying.